Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

VENUS PHARMA products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer · Lahore · Pakistan

Lahore-based pharmaceutical manufacturer with human-health and veterinary product divisions and a portfolio spanning tablets, capsules, injectables and other dosage forms.

VENUS PHARMA products in Pakistan

VENUS PHARMA has 143 medicine presentations registered in Pakistan under 76 brands, covering 62 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and Pain & musculoskeletal. Its brands with the most registered strengths and packs are DEXAMETHASONE (Dexamethasone), Metrove (Metronidazole), Valron (Diclofenac) and Gentamicin (Gentamicin). 142 products have an official DRAP price on MedInfoBase. See all 76 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation10 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date1 Jul 2025Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
23 KM, Multan Road, Lahore 54000, Pakistan · 54000
Phone
+92 42 35966651; +92 42 36300875
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000300 Venus Pharma. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000300 143 linked products · source seen 10 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx158public portfolio records represented
REG110unique registrations represented
IDX143indexed MedInfoBase presentations
SRC2additional source-observed presentations
R+13registry-only registrations
VER14registry-verified exact registrations
PKR142current validated price records
G62generic molecules in indexed catalogue
DF6dosage-form groups
TA12therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage90%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage91%
priced packs safely normalized per unit
Comparable-market coverage59%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixVENUS PHARMAShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/venus-pharmaGenerated 10 Nov 2026Anti-infectives37 · 26%Gastrointestinal & hepatology22 · 15%Pain & musculoskeletal21 · 15%CNS & mental health16 · 11%Anesthesia & critical care13 · 9%Respiratory & allergy11 · 8%Cross-therapeutic & anti-inflamma…7 · 5%Other therapeutic areas16 · 11%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioVENUS PHARMADistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/venus-pharmaGenerated 10 Nov 2026143presentationsTablet79 · 55%Injection53 · 37%Capsule4 · 3%Ointment3 · 2%Cream2 · 1%Infusion2 · 1%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionVENUS PHARMACurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/venus-pharmaGenerated 10 Nov 202684comparable productsBelow peer median72 · 86%Near peer median6 · 7%Above peer median6 · 7%Company median price position-35.1%Lowest-price equivalents41Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsVENUS PHARMACompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/venus-pharmaGenerated 10 Nov 2026Mediate Pharmaceutical Pvt Ltd25 shared40% overlapNeutro Pharma (Pvt.) Ltd.,25 shared40% overlapZafa Pharmaceutical Laboratories (P…23 shared37% overlapMS SIZA INTERNATIONAL PVT LTD.23 shared37% overlapBosch Pharmaceuticals (Pvt) Ltd.22 shared35% overlapSAFE PHARMACEUTICAL (PVT) LTD22 shared35% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet79 products
Injection53 products
Capsule4 products
Ointment3 products
Cream2 products
Infusion2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where VENUS PHARMA is priced against the market

84 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers95Distinct registrations among indexed, published, presentation-validated products only
Verified price observations142
Products with a verified price142
Products with multiple price observations0
Source records with multiple versions143
Latest portfolio source check12 Oct 2026
Latest effective price date1 Jul 2025
Latest source observation10 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

110 unique registration(s) · 143 indexed presentation(s) · 2 additional source-observed presentation(s) · 13 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Adrenaline Adrenaline (epinephrine) 1 mg Injection 10ml 013619 PKR 12.01 PKR 1.20/mL No comparator
Adrenaline Adrenaline (epinephrine) 1 mg Injection 3x1ml 013619 PKR 33.95 PKR 11.32/mL No comparator
Alcozin Azithromycin 250 mg Tablet 6's 106009 PKR 188.72 PKR 31.45/tablet 🔒 Pharma Pro
Alcozin Azithromycin 500 mg Tablet 6's 108278 PKR 345.98 PKR 57.66/tablet 🔒 Pharma Pro
Andol Tramadol HCl 50 mg Injection 2ml x 5’s 087501 PKR 190.12 PKR 19.01/mL No comparator
Andol Injection 2ccRegistry verified Tramadol Hydrochloride — — — 010924-EXOfficial source ↗ No indexed price — —
Angilock Losartan 50 mg Tablet 2x10’s 030758 PKR 339.50 PKR 16.98/tablet 🔒 Pharma Pro
Ann-Vil Pheniramine Maleate 22.7 mg Tablet 1x500 jar pack 028325 PKR 90.98 — No comparator
Ann-Vil Pheniramine Maleate 22.7 mg Tablet 25x10 028325 PKR 74.69 PKR 0.30/tablet No comparator
Ann-Vil Pheniramine Maleate 22.7 mg Tablet 50x10 028325 PKR 108.64 PKR 0.22/tablet No comparator
Annvil Pheniramine Maleate 25 mg Injection 100x2ml 012083 PKR 464.43 PKR 2.32/mL No comparator
Apresolin Hydralazine 20 mg Injection 1's 065823 PKR 33.95 PKR 33.95/vial/unit No comparator
Atropine Atropine 1 mg Injection 1x100's ampoule 027753 PKR 655.54 — No comparator
Avium Clarithromycin 250 mg Tablet 10's 115478 PKR 304.59 PKR 30.46/tablet 🔒 Pharma Pro
Chloramphenicol Chloramphenicol 1 g Capsule 3.5gm 019333 PKR 16.30 PKR 4.66/g No comparator
Chloroquine Phosphate Chloroquine 40 mg Injection 100x5ml 012086 PKR 397.86 PKR 0.80/mL No comparator
Ciloxon Ciprofloxacin 500 mg Tablet 1x10 062784 PKR 176.54 PKR 17.65/tablet 🔒 Pharma Pro
Ciloxon Ciprofloxacin 250 mg Tablet 1x10 062785 PKR 256.24 PKR 25.62/tablet 🔒 Pharma Pro
Ciloxon Ciprofloxacin 200 mg/100 mL IV infusion 100ml 095741 PKR 135.80 PKR 1.36/mL 🔒 Pharma Pro
Col-D3 Cholecalciferol 5 mg Injection 1mlx5's 077216 PKR 634.17 PKR 126.83/mL 🔒 Pharma Pro
Col-D3 Cholecalciferol 5 mg Injection 1x1ml 077216 PKR 149.38 PKR 149.38/mL 🔒 Pharma Pro
D-verine Drotaverine HCl 40 mg Injection 2mlx25's 095744 PKR 325.91 PKR 6.52/mL No comparator
D-verine Drotaverine HCl 40 mg Injection 5's 095744 PKR 67.90 PKR 13.58/vial/unit No comparator
D-verine Drotaverine HCl 40 mg Tablet 2x10's 097610 PKR 54.32 PKR 2.72/tablet No comparator
Deltasone Prednisolone 5 mg Tablet 1000's 057356 PKR 2,036.97 PKR 2.04/tablet 🔒 Pharma Pro
Deltasone Prednisolone 5 mg Tablet 100’s 057356 PKR 230.86 PKR 2.31/tablet 🔒 Pharma Pro
DEXAMETHASONE Dexamethasone 4 mg Injection 30ml 012089 PKR 51.54 PKR 1.72/mL 🔒 Pharma Pro
DEXAMETHASONE Dexamethasone 4 mg Injection 25 amps 012089 PKR 114.06 PKR 4.56/vial/unit 🔒 Pharma Pro
DEXAMETHASONE Dexamethasone 4 mg Injection 5ml 012089 PKR 19.02 PKR 3.80/mL 🔒 Pharma Pro
DEXAMETHASONE Dexamethasone 0.5 mg Tablet 1x1000 jar pack 028311 PKR 244.44 — No comparator
DEXAMETHASONE Dexamethasone 0.5 mg Tablet 3x10’s 028311 PKR 16.30 PKR 0.54/tablet 🔒 Pharma Pro
Diazocin Diazepam 5 mg Injection 2mlx100's 097633 PKR 2,712.20 PKR 13.56/mL No comparator
Diazocin Diazepam 5 mg Injection 2ml x 5’s 097633 PKR 173.82 PKR 17.38/mL No comparator
Diazocin Diazepam 5 mg Injection 2mlx25's 097633 PKR 678.66 PKR 13.57/mL No comparator
Diomine Dimenhydrinate 50 mg Injection 25x1ml 027752 PKR 203.70 PKR 8.15/mL No comparator
Ephedrine Ephedrine 30 mg Tablet 1x1000’s 062898 PKR 271.60 PKR 0.27/tablet 🔒 Pharma Pro
Eseft 40 mg IV InjectionRegistry verified Esomeprazole as Sodium — — — 127433Official source ↗ No indexed price — —
Flaxove Ofloxacin 200 mg Tablet 10's 062786 PKR 156.17 PKR 15.62/tablet 🔒 Pharma Pro
Flunoate Fluphenazine decanoate 25 mg Injection 1mlx10's 121591 PKR 1,145.19 PKR 114.52/mL No comparator
Flunoate Fluphenazine decanoate 25 mg Injection 1mlx1's 121591 PKR 124.54 PKR 124.54/mL No comparator
Gentamicin Gentamicin 40 mg Injection 2x2ml 013618 PKR 67.90 PKR 16.98/mL 🔒 Pharma Pro
Gentamicin Gentamicin 40 mg Injection 25ml 013619 PKR 17.02 PKR 0.68/mL 🔒 Pharma Pro
Gentamicin Gentamicin 40 mg Injection 100x1ml 013619 PKR 658.85 PKR 6.59/mL 🔒 Pharma Pro
Gentamicin Gentamicin 40 mg Injection 100x1ml 013620 PKR 840.40 PKR 8.40/mL 🔒 Pharma Pro
Haloridol Vee Haloperidol 5 mg Injection 1mlx25's 121590 PKR 250.61 PKR 10.02/mL No comparator
Hyoscine Hyoscine butylbromide 20 mg Injection 2mlx30's 064545 PKR 162.96 PKR 2.72/mL 🔒 Pharma Pro
Iron-Vee Iron 100 mg/5 mL Injection 5mlx5's 119530 PKR 1,871.98 PKR 74.88/mL 🔒 Pharma Pro
Keukin Quetiapine 25 mg Tablet 3x10's 087502 PKR 625.07 PKR 20.84/tablet 🔒 Pharma Pro
Keukin Quetiapine 25 mg Tablet 10's 087502 PKR 217.04 PKR 21.70/tablet 🔒 Pharma Pro
Keukin Quetiapine 300 mg Tablet 10's 087504 PKR 1,406.41 PKR 140.64/tablet 🔒 Pharma Pro
A to Z

All 76 VENUS PHARMA brands in Pakistan

  • Adrenaline Adrenaline (epinephrine) · 1 mg injection
  • Alcozin Azithromycin · 250 mg tablet, 500 mg tablet
  • Andol Tramadol HCl · 50 mg injection
  • Angilock Losartan · 50 mg tablet
  • Ann-Vil Pheniramine Maleate · 22.7 mg tablet
  • Annvil Pheniramine Maleate · 25 mg injection
  • Apresolin Hydralazine · 20 mg injection
  • Atropine Atropine · 1 mg injection
  • Avium Clarithromycin · 250 mg tablet
  • Chloramphenicol Chloramphenicol · 1 g capsule
  • Chloroquine Phosphate Chloroquine · 40 mg injection
  • Ciloxon Ciprofloxacin · 200 mg/100 mL infusion, 250 mg tablet, 500 mg tablet
  • Col-D3 Cholecalciferol · 5 mg injection
  • D-verine Drotaverine HCl · 40 mg injection, 40 mg tablet
  • Deltasone Prednisolone · 5 mg tablet
  • DEXAMETHASONE Dexamethasone · 0.5 mg tablet, 4 mg injection
  • Diazocin Diazepam · 5 mg injection
  • Diomine Dimenhydrinate · 50 mg injection
  • Ephedrine Ephedrine · 30 mg tablet
  • Flaxove Ofloxacin · 200 mg tablet
  • Flunoate Fluphenazine decanoate · 25 mg injection
  • Gentamicin Gentamicin · 40 mg injection
  • Haloridol Vee Haloperidol · 5 mg injection
  • Hyoscine Hyoscine butylbromide · 20 mg injection
  • Iron-Vee Iron · 100 mg/5 mL injection
  • Keukin Quetiapine · 25 mg tablet, 300 mg tablet
  • Lipinil-10 Simvastatin · 10 mg tablet
  • Lipinil-20 Simvastatin · 20 mg tablet
  • Matamax Metoclopramide · 10 mg tablet
  • Matamex Metoclopramide · 5 mg injection
  • Metovine Metronidazole + Diloxanide furoate · 400 mg + 500 mg tablet
  • Metrove Metronidazole · 200 mg tablet, 400 mg tablet, 5 mg injection
  • Midazocine Midazolam · 1 mg injection
  • Mikacin Amikacin · 100 mg injection, 250 mg injection, 500 mg injection
  • Ondansetron Ondansetron · 8 mg/4 mL injection
  • Oxytocin Oxytocin · 5 IU injection
  • Phenobarbital Phenobarbital · 200 mg/mL injection, 30 mg tablet
  • Polyvee Ointment Polymyxin B + Bacitracin · 10000 units/g + 500 units/g ointment
  • Protic Neostigmine methylsulfate · 0.5 mg injection
  • Quinine Quinine dihydrochloride · 300 mg injection
  • Quinine Bisulphate Quinine bisulfate · 300 mg tablet
  • Spinocaine Bupivacaine · 5 % injection
  • Threesil Magnesium trisilicate + Aluminium hydroxide · 500 mg + 250 mg tablet
  • Valron Diclofenac · 25 mg injection, 50 mg tablet
  • Valron-100 SR Diclofenac · 100 mg tablet
  • Varax Ephedrine · 10 mg tablet
  • Vee-Bufen Ibuprofen · 200 mg tablet, 400 mg tablet
  • Veebufen Comp Ibuprofen · 200 mg tablet
  • Veebufen Comp. Forte Ibuprofen · 400 mg tablet
  • Veerium Atracurium besylate · 50 mg/5 mL injection
  • Vegamet – 400 Cimetidine · 400 mg tablet
  • Vegamet-200 Cimetidine · 200 mg tablet
  • Venomox Moxifloxacin · 400 mg tablet
  • Vensidol Paracetamol · 500 mg tablet
  • Ventomol Salbutamol · 0.5 mg injection
  • Ventomol 2 Salbutamol · 2 mg tablet
  • Ventomol 4 Salbutamol · 4 mg tablet
  • Veprazole-20 Omeprazole enteric coated pellets · 20 mg capsule
  • Vepressor Ephedrine · 50 mg injection
  • Vetran Trimethoprim · 80 mg tablet
  • Vetran DS Sulfamethoxazole + Trimethoprim · 160 mg + 800 mg tablet
  • Vio – Dine Loratadine · 10 mg tablet
  • Vio-Aqua Water for Injection · 5 mL injection
  • Vio-Chlor Chloroquine · 150 mg tablet
  • Vio-fung Griseofulvin · 500 mg tablet
  • Vio-zone Propyphenazone · 175 mg tablet
  • Viobet N Betamethasone + Neomycin, Betamethasone valerate + Neomycin sulfate · 0.1 % + 0.5 % cream, 0.1% + 0.5% cream
  • Viobet N Ointment Betamethasone + Neomycin · 0.1 % + 0.5 % ointment
  • Viodol Paracetamol · 1 g/100 mL infusion, 500 mg tablet
  • Vioflox-500 Levofloxacin · 500 mg tablet
  • Violome Diphenoxylate HCl · 2.5 mg tablet
  • Viopam-5 Diazepam · 5 mg tablet
  • Viriton Chlorpheniramine · 4 mg tablet
  • Vitamin K1 Phytomenadione · 10 mg/mL injection, 2 mg/mL injection
  • Xylex Lidocaine · 2 % injection
  • Zeevin Naproxen · 250 mg tablet, 500 mg tablet
Questions

VENUS PHARMA: common questions

How many products does VENUS PHARMA have in Pakistan?

VENUS PHARMA has 143 registered medicine presentations in Pakistan, sold under 76 brands and covering 62 generic medicines.

What are the main brands of VENUS PHARMA?

By number of registered strengths and packs, its largest brands are DEXAMETHASONE (Dexamethasone), Metrove (Metronidazole), Valron (Diclofenac), Gentamicin (Gentamicin) and Phenobarbital (Phenobarbital). This is not a sales ranking.

Which therapy areas does VENUS PHARMA cover?

The most products are in Anti-infectives (37), Gastrointestinal & hepatology (22), Pain & musculoskeletal (21), CNS & mental health (16) and Anesthesia & critical care (13).

Where can I see VENUS PHARMA medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). VENUS PHARMA — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 10, 2026, from https://medinfobase.com/company/venus-pharma/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9